WASHINGTON, Jan 11 (Reuters) - The U.S. Food and Drug Administration is focused on reviewing at-home and other COVID-19 tests, particularly those that can be manufactured at scale, Acting FDA Commissioner Janet Woodcock said at a Senate hearing on Tuesday. (Reporting by Susan Heavey)